Controlling spheroid attachment improves pancreatic beta cell differentiation from human iPS cells
{{output}}
Regenerative medicine using human induced pluripotent stem cells (hiPSCs) is available for treating type 1 diabetes; however, the efficiency and maturation of hiPSC differentiation into pancreatic beta cells requires improvement. Various protocols, including t... ...
